title: Expression of epidermal growth-factor receptor in lymphangiomatosis: a new therapeutic target?
authors.affiliation: Tissue Engineering Network, Medical School Hannover, Germany. mertsching.heike@mh-hannover.de
authors.forename: Heike
authors.initials: H
authors.lastname: Mertsching
authors.forename: Thorsten
authors.initials: T
authors.lastname: Walles
authors.forename: Gesa
authors.initials: G
authors.lastname: Bakker
authors.forename: Ingeborg
authors.initials: I
authors.lastname: Wildfang
authors.forename: Paolo
authors.initials: P
authors.lastname: Macchiarini
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis*; D001707:Biopsy, Needle; D066246:ErbB Receptors / Q000032:analysis* / Q000187:drug effects; D006801:Humans; D007150:Immunohistochemistry; D008202:Lymphangioma / Q000188:drug therapy / Q000473:pathology*; D008479:Mediastinal Neoplasms / Q000188:drug therapy / Q000473:pathology*; D009378:Neoplasms, Multiple Primary / Q000473:pathology*; D012680:Sensitivity and Specificity
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D066246:ErbB Receptors